A股異動丨普利特大漲逾8% 擬收購振興化工80%股權,提高受阻胺類光穩定劑技術水平
格隆匯3月20日丨普利特(002324.SZ)大漲逾8%,報17.07元,總市值90億元。普利特昨日公佈,公司於2020年3月18日與宿遷市振興化工有限公司(以下簡稱“振興化工”)股東陳建華簽署了《股權轉讓意向書》。陳建華擬將持有振興化工80%的股權轉讓給公司。公司在完成對振興化工的盡職調查後,將與陳建華簽署正式《股權轉讓協議》,振興化工80%股權轉讓價款為人民幣1.0億元。收購振興化工是公司特殊化學品產業板塊,繼重組帝盛集團之後進一步延伸發展。能進一步提高公司在受阻胺類光穩定劑領域的技術水平,增強公司在光穩定劑行業的競爭能力和市場地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.